Инсулинорезистентность и нефропатия при ожирении у детей
Аннотация
В обзоре приводятся сведения о механизмах развития инсулинорезистентности (ИР) при избыточном накоплении жировой ткани и влиянии нарушений углеводного и жирового обмена на функцию почек. Представлены данные о причинах возникновения ожирения и ИР на ранних этапах онтогенеза. Подчеркнута значимость ранней диагностики ИР и её коррекции при приобретенных болезнях почек у детей.
Об авторах
Наталия Николаевна Смирнова
Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Северо-Западный Федеральный медицинский исследовательский центр им. В.А. Алмазова
Россия
Россия
Наталья Борисовна Куприенко
Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Северо-Западный Федеральный медицинский исследовательский центр им. В.А. Алмазова
Россия
Россия
Список литературы
1. Hedley A, Ogden CL, Johnson CL et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847- 2850
2. Weedon MN. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316:889-894
3. Sofia Inez et al. Obesity Facts 2008;1:138-145 Published online: June 20, 2008 DOI: 10.1159/000137665
4. Adelman RD, Restaino JG, Alon US, Blowley DL Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138:482-485
5. Royer P, Habib R, Mathieu H, Coutecuisse V. L’hypolasie rénale bilaterale congénitale avec réduction du nombre et hypertrophie des néphrons chez l’enfant. Annales de Pédiatrie 1962;9:133-140
6. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81: 440-447
7. Cohen AH. Massive obesity and the kidney. Am J Pathol1975; 81:17-130
8. D’Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46:1223-1241
9. Adelman RD, Restaino JG, Alon US, Blowley DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138:482-485
10. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498-1509
11. Schwimmer JA, Markowitz GS, Valeri AM et al. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass. Clin Nephrol 2003; 60(4):233-241
12. Tomaszewski M, Charchar FJ, Maric C et al. Glomerular hyper filtration: a marker of metabolic risk. Kidney Int 2007; 71:816-821
13. Смирнов АВ, Румянцев АШ, Добронравов ВА, Каюков ИГ. XXI век - время интегративной нефрологии. Нефрология 2015; 19(2): 26-31 [Smirnov AV, Rumyantsev ASh, Dobronravov VA, Kayukov IG. XXI century - the time of integrative nephrology. Nephrology 2015; 19(2): 26-31]
14. Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end stage renal disease. J Am Soc Nephrol 2008; 19:151-157
15. Hovi P, Andersson S, Raikkonen K et al. Ambulatory blood pressure in young adults with very low birth weight. J Pediatr 2010; 156: 54-59
16. Phillips DI. Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 1996; 39: 1119-1122
17. Gluckman P, Hanson M (eds). The Fetal Matrix: Evolution, Development and Disease. Cambridge: Cambridge University Press, 2005
18. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004; 56: 311-317
19. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 1999; 353: 1789-1792
20. Day IN, Chen XH, Gaunt TR et al. Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster. J Clin Endocrinol Metab 2004; 89: 5569-5576
21. Brenner BM, Lawler EV, Mackenzie HS. The hyper filtration theory: a paradigm shift in nephrology. Kidney Int 1996; 49: 1774-1777
22. Ingelfinger JR. Pathogenesis of perinatal programming. Curr Opin Nephrol Hypertens 2004; 13:459-464
23. Leeson CP, Kattenhorn M, Morley R et al. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001; 103:1264-1268
24. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 5: 78-84
25. Juul A, Scheike T, Davidsen M et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002; 106:939-944
26. Johnston LB, Dahlgren J, Leger J et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 2003; 88:4805-4810
27. Ricardo Sesso, Maria C.P Franco. Abnormalities in Metalloproteinase Pathways and IGF-I Axis: A Link between Birth Weight, Hypertension, and Vascular Damage in Childhood. American journal of hypertension 2010; 23 (1): 6-11
28. Carolyn L. Abitbol; Maria M. Rodriguez. Obesity-Related Nephropathy in Children. Pediatr Health 2009; 3(2):141-153
29. Carolyn LA, Chandar J, Rodriguez MM et al. Obesity and preterm birth: additive risks in the progression of kidney disease in children. Pediatr Nephrol 2010; 23(3):413-419
30. Kursawe R. Metabolic Syndrome in Pediatrics: The Role of Lipid Partitioning. Ann Pediatr Child Health 2014; 2(1): 1007
31. Siew ED, Ikizler TA. Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib Nephrol 2008; 161:138-144
32. Hien Phama, Kristina M. Utzschneiderb and Ian H. de Boera Measurement of insulin resistance in chronic kidney disease. Current Opinion in Nephrology and Hypertension 2011; 20:640-646
33. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365:1333-1346
34. van Raalte DH, Brands M, van der Zijl NJ, et al. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia Aug 2011; 54(8):2103-2112
35. George Bayliss, Larry A. Weinrauch, John A. D’Elia Pathophysiology of Obesity-related renal Dysfunction Contributed to Diabetic nephropathy. Curr Diab Rep DOI 10. 1007/s11892-012-0288-1
36. Paula FJA, Rosen CJ. Bone remodeling and Energy metabolism: New perspectives. Bone research 2013; 1(1): 72-84. doi: 10.4248/BR201301005
37. Tai K, Need AG, Horowitz M, Chapman IM. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008; 24(3): 279-285
38. Дудинская ЕН, Ткачева ОН. Роль витамина Д в развитии артериальной гипертензии. Кардиоваскулярная терапия и профилактика 2012; 11(3): 77-81 [Dudinskaia EN, Tkacheva ON. Rol' vitamina D v razvitii arterial'noi' gipertenzii. Kardiovaskuliarnaia terapiia i profilaktika 2012; 11(3): 77-81]
39. Karolina DS, Silambarasan M, Armugam A, Yeyaseelan K. MicroRNAs and Endothelial Dysfunction in Relation to Obesity and Type2 Diabetes J Mol Genet med. S1: 011.doi:10.4172/1747-0862.S1-011)
40. Ranganath Muniyappa, James R. Sowers Role of insulin resistance in endothelial dysfunction. Reviews in Endocrine and Metabolic Disorders 2013; 14 (1): 5-12
41. Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin. Diabetologia 1984; 27 ( 3): 351-357
42. Shoko Horita, George Seki, Hideomi Yamada et al. Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport. International Journal of Hypertension 2011; Article ID 391762, 8 pages http://dx.doi.org/10.4061/2011/391762
43. Tsimaratos M, Roger F, Chabardès D et al. C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 2003; 46 (1): 124-131
44. DeFronzo RA, Cooke CR, Andres R. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. Journal of Clinical Investigation 1975; 55 (4): 845-855
45. Тюзиков ИА. Инсулинорезистентность как системный фактор патогенеза заболеваний почек. Сахарный диабет 2014; (1): 47-56 [Tiuzikov IA.Insulinorezistentnost' kak sistemny'i' faktor patogeneza zabolevanii' pochek. Saharny'i' diabet 2014; (1): 47-56]
46. Simpkin A, Cochran E, Cameron F et al. Insulin receptor and the kidney: nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiology 2014;128: 55-61 DOI: 10.1159/000366225
47. Becker B, Kronenberg F, Kielstein J et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005; 16: 1091-1098
48. Kaartinen K, Syrjanen J, Porsti I et al. Insulin resistance and the Progression of IgA glomerulonephritis. Nephrol Dial Transplant 2006; 12: 1-6
49. Леванковская ЕИ, Швецов МЮ, Зилов АВ, Шилов ЕМ. Инсулинорезистентность как ранний предиктор неблагоприятного течения хронической болезни почек недиабетической этиологии. Нефрология и диализ 2010; 12(2): 74-81 [Levankovskaia EI, Shvetcov MIu, Zilov AV, Shilov EM. Insulinorezistentnost' kak rannii' prediktor neblagopriiatnogo techeniia khronicheskoi' bolezni pochek nediabeticheskoi' e'tiologii. Nefrologiia i dializ.2010; 12(2): 74-81]
50. Казакова ИА. Клинико-патогенетические механизмы прогрессирования хронического гломерулонефрита при формировании хронической почечной недостаточности. Автореф. дис..д-ра мед.наук. Пермь, 2005 [Kazakova IA. Cliniko-patogeneticheskie mehanizmy' progressirovaniia khronicheskogo glomerulonefrita pri formirovanii khronicheskoi' pochechnoi' nedostatochnosti. Avtoreferat dis.d.m.n. Perm', 2005]
51. Chen J, Muntner P, Hamm L et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephron 2003; 14: 469-477
52. Sechi L, Catena C, Zingaro L et al. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002; Vol. 51: 1226-1232
53. Jiaping Jin, Bo Jin, Songming Huang et al. Insulin resistance in children with primary nephrotic syndrome and normal renal function. Pediatr Nephrol 2012; 27 (10):1901-1909
Рецензия
Для цитирования:
Смирнова Н.Н., Куприенко Н.Б. Инсулинорезистентность и нефропатия при ожирении у детей. Нефрология. 2016;20(3):28-34.
For citation:
Smirnova N.N., Kuprienko N.B. Insulin resistance and nephropathy in obese children. Nephrology (Saint-Petersburg). 2016;20(3):28-34. (In Russ.)
Просмотров:
449
Послать статью по эл. почте 